Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Ishita Sen"'
Autor:
Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa CB
Publikováno v:
Diagnostics, Vol 13, Iss 13, p 2221 (2023)
Tumour sampling is indispensable to diagnostic and therapeutic decision making. Thus, 18F-FDG PET/CT has the potential to accurately discriminate between viable and non-viable tissues due to its ability to characterise the metabolism of visible tissu
Externí odkaz:
https://doaj.org/article/a53148a1b8f04a6fbe601b31facf752c
Publikováno v:
Bengal Journal of Otolaryngology and Head Neck Surgery, Vol 28, Iss 2 (2020)
Introduction Second primary malignancy as squamous cell carcinoma of larynx is rare after squamous cell carcinoma of buccal mucosa. Case Report A 47 year old male patient presented with a painless, progressive ulcer of left buccal mucosa nea
Externí odkaz:
https://doaj.org/article/bb29696a5c1b45c79a4e7c60654e29b3
Publikováno v:
Asian Journal of Surgery, Vol 29, Iss 2, Pp 86-91 (2006)
Pulmonary embolism (PE) is the most severe complication of deep venous thrombosis (DVT). There have been very few studies to assess the prevalence of PE in Asian patients. The objective of this study was to define the prevalence of PE in patients pre
Externí odkaz:
https://doaj.org/article/90f61d5b536d42988683e8715de4da22
Autor:
Parul Thakral, Divya Manda, Subha Shankar Das, Pankaj Tandon, Virupakshappa CB, Dharmender Malik, Ishita Sen
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 38:8-14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::243d937bc743dbe204ada5ef02b9b98e
https://doi.org/10.1089/cbr.2022.0029
https://doi.org/10.1089/cbr.2022.0029
Autor:
Ishita Sen
Publikováno v:
The Review of Financial Studies. 36:2175-2223
Variable annuities, the largest liability of U.S. life insurers, are investment products containing long-dated minimum return guarantees. I show that guarantees with similar economic risks are treated differently by regulation and these differences i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df3a875ec321570b7ad7e04f30b8bdcd
https://doi.org/10.1093/rfs/hhac083
https://doi.org/10.1093/rfs/hhac083
Publikováno v:
Finance and Economics Discussion Series. 2022:1-93
Homeowners’ insurance, a $15 trillion market by coverage, provides households financial protection from climate losses. Insurance premiums (rates) are subject to significant regulations at a state level in the United States. Using novel data on fil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::534ab2336bace6b5e9b090002c7369c6
https://doi.org/10.17016/feds.2022.064
https://doi.org/10.17016/feds.2022.064
Autor:
CB, Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa
Publikováno v:
Diagnostics; Volume 13; Issue 13; Pages: 2221
Tumour sampling is indispensable to diagnostic and therapeutic decision making. Thus, 18F-FDG PET/CT has the potential to accurately discriminate between viable and non-viable tissues due to its ability to characterise the metabolism of visible tissu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::ec47efe47af09625d5d3128abb4792ab
Autor:
Parul Thakral, Subha Shankar Das, Shweta Dhiman, Divya Manda, C.B. Virupakshappa, Dharmender Malik, Ishita Sen
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::486ca4f64a0a33ac14c32ad0a6764ff1
https://doi.org/10.1089/cbr.2022.0080
https://doi.org/10.1089/cbr.2022.0080
Autor:
Divya, Manda, Parul, Thakral, Ishita, Sen, Subha Shankar, Das, Virupakshappa, Cb, Dharmender, Malik
Publikováno v:
Clinical Nuclear Medicine.
Differentiating infection and sterile inflammation is the main clinical concern of clinicians as they are closely related to each other. Although 18 F-FDG PET/CT imaging is widely used, its main disadvantage is its lack of specificity to discriminate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6655f2d5b10d916ecac551c7d4f8ff66
https://doi.org/10.1097/rlu.0000000000004317
https://doi.org/10.1097/rlu.0000000000004317
Autor:
Vinod Raina, Parul Thakral, Vineet Pant, Priya Tiwari, Subha Shankar Das, Ishita Sen, Divya Manda
Publikováno v:
Annals of Nuclear Medicine. 35:794-810
225Ac-PSMA-617 therapy has shown good response in many recent studies. We report our experience of targeted alpha therapy with 225Ac-PSMA-617 in mCRPC patients who have failed therapy with taxanes. Thirty-eight patients with CRPC with progressive dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b51dc9af1cd5839ce2efb1a2a5030b99
https://doi.org/10.1007/s12149-021-01617-4
https://doi.org/10.1007/s12149-021-01617-4